HLSQ AMEX
Tessera Defense and Homeland Security Inc
1W: -31.8%
YTD: -97.7%
$0.36
-0.02 (-6.44%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0M
52W Range0.3332-2.16
Volume657,045
Avg Volume1,030,435
Beta1.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael Oster
Employees20
SectorHealthcare
IndustryBiotechnology
IPO Date2026-09-11
Websitebiomx.com
16192 Coastal Highway
Dover, DE 19958
US
Dover, DE 19958
US
About Tessera Defense and Homeland Security Inc
Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dover, DE.
Recent Insider Trades
No insider trades found